Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-314truefalse2024-04-01medical services4trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08649434 2024-04-01 2025-03-31 08649434 2023-04-01 2024-03-31 08649434 2025-03-31 08649434 2024-03-31 08649434 c:Director1 2024-04-01 2025-03-31 08649434 d:CurrentFinancialInstruments 2025-03-31 08649434 d:CurrentFinancialInstruments 2024-03-31 08649434 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 08649434 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 08649434 d:ShareCapital 2025-03-31 08649434 d:ShareCapital 2024-03-31 08649434 d:RetainedEarningsAccumulatedLosses 2025-03-31 08649434 d:RetainedEarningsAccumulatedLosses 2024-03-31 08649434 c:FRS102 2024-04-01 2025-03-31 08649434 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 08649434 c:FullAccounts 2024-04-01 2025-03-31 08649434 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08649434 2 2024-04-01 2025-03-31 08649434 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 08649434










KINGSNORTH MEDICAL SERVICES LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
KINGSNORTH MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 08649434

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
366,792
373,562

Cash at bank and in hand
  
161,963
169,176

  
528,755
542,738

Creditors: amounts falling due within one year
 6 
(192,990)
(194,001)

Net current assets
  
 
 
335,765
 
 
348,737

Net assets
  
335,765
348,737


Capital and reserves
  

Called up share capital 
  
80
80

Profit and loss account
  
335,685
348,657

  
335,765
348,737


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr M J L Davies
Director

Date: 5 December 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
KINGSNORTH MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Kingsnorth Medical Services Limited is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is Kingsnorth Medical Practice, Ashford Road, Ashford, Kent, TN23 3ED.
The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Revenue from the provision of services is recognised in the period in which the services are provided, when the amount of revenue can be measured reliably and it is probable that the Company will receive the consideration due.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 2

 
KINGSNORTH MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements.


4.


Employees

The average monthly number of employees, including directors, during the year was 4 (2024 - 4).


5.


Debtors

2025
2024
£
£


Trade debtors
363,290
370,379

Prepayments and accrued income
3,502
3,183

366,792
373,562


Page 3

 
KINGSNORTH MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
57,753
43,052

Corporation tax
130,009
146,374

Other creditors
2,708
2,235

Accruals and deferred income
2,520
2,340

192,990
194,001



7.


Related party transactions

During the financial year the company provided services to Kingsnorth Medical Practice on a normal trading basis in the sum of £696,205 (2024 - £597,778) which is included within turnover, of which £338,638 (2024 - £355,265) was outstanding at the year end. The director is also a partner in Kingsnorth Medical Practice.

 
Page 4